Enxin Wang

1.4k total citations
20 papers, 365 citations indexed

About

Enxin Wang is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Enxin Wang has authored 20 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Enxin Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and COVID-19 Clinical Research Studies (5 papers). Enxin Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and COVID-19 Clinical Research Studies (5 papers). Enxin Wang collaborates with scholars based in China, United States and Australia. Enxin Wang's co-authors include Lei Liu, Juli Feigon, Shiva Malek, Laishun Chen, Caihua Yang, Yuling Li, Christopher Patten, Huichen Li, Yejing Zhu and Shoujie Zhao and has published in prestigious journals such as Biochemistry, Scientific Reports and International Journal of Cancer.

In The Last Decade

Enxin Wang

18 papers receiving 360 citations

Peers

Countries citing papers authored by Enxin Wang

Since Specialization

Citations

This map shows the geographic impact of Enxin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enxin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enxin Wang more than expected).

Fields of papers citing papers by Enxin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enxin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enxin Wang. The network helps show where Enxin Wang may publish in the future.

Co-authorship network of co-authors of Enxin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Enxin Wang. A scholar is included among the top collaborators of Enxin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enxin Wang. Enxin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted Analysis 2025 ·Annals of Surgical Oncology ·Shoujie Zhao, Jinming Zhu, Yejing Zhu, Jia Jia, Weirong Ren, Enxin Wang, Jun Zhu, (unknown), Liangzhi Wen, Xing Chen, Man Yang, Bo Wang, (unknown), (unknown), Yan Zhao, Xingshun Qi, Wenbing Wu, Lei Liu	0
2	Identification of transarterial chemoembolization candidates in advanced hepatocellular carcinoma patients classified solely by performance status 1: a multicenter retrospective study 2025 ·Scientific Reports ·(unknown), Zhexuan Wang, Litian Ma, Junli Gou, (unknown), (unknown), (unknown), Tao Wang, Yong Liang, Yongchao Zhang, Enxin Wang, Yang Bai	1
3	Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter study 2025 ·Surgical Endoscopy ·Shoujie Zhao, Yejing Zhu, Jinming Zhu, (unknown), Enxin Wang, Jun Zhu, Liangzhi Wen, Yan Zhao, Man Yang, (unknown), (unknown), Jia Jia, Wenbing Wu, Weirong Ren, Xing Chen, (unknown), Xingshun Qi, Xilin Du, Lei Liu	0
4	Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS 2022 ·JHEP Reports ·(unknown), Kai Li, (unknown), Yong Lv, Qiuhe Wang, Zheng‐Yu Wang, Bohan Luo, Jing Niu, Ying Zhu, Wengang Guo, Wei Bai, Enxin Wang, Dongdong Xia, Zhexuan Wang, Xiaomei Li, Jie Yuan, Zhanxin Yin, Jonel Trebicka, Guohong Han	25
5	Clinical course and outcomes of COVID-19 patients with chronic obstructive pulmonary disease 2022 ·Medicine ·Yang Bai, Liang Wen, (unknown), Jianan Li, Guo Chen, Xiao‐Bin Zhang, Jiaming Yang, Yushu Dong, Litian Ma, (unknown), (unknown), Enxin Wang	1
6	Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling 2021 ·Molecular Cancer ·Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, (unknown), Jie Hu, Lintao Jia, Lei Liu	84
7	Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study 2021 ·The American Journal of Gastroenterology ·Yong Lv, (unknown), Kai Li, Zhengyu Wang, Wengang Guo, Bohan Luo, Jianhong Wang, Qiuhe Wang, Enxin Wang, Dongdong Xia, Xiaomei Li, Jie Yuan, Na Han, Jing Niu, Zhanxin Yin, Daiming Fan, Guohong Han	34
8	Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China 2021 ·Frontiers in Medicine ·Yang Bai, Enxin Wang, Shoujie Zhao, (unknown), Yejing Zhu, Yongchao Zhang, Liang Cao, Haitao Liu, Yushu Dong, Fang Wang, Guobiao Liang, Lei Liu	7
9	The CB index predicts prognosis of critically ill COVID-19 patients 2020 ·Annals of Translational Medicine ·Liang Cao, Sha Zhang, Enxin Wang, Yongchao Zhang, Yang Bai, Xi Luo, Zhe Li, Feng Li, Ling Tao, Haitao Liu	1
10	Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization 2020 ·World Journal of Gastroenterology ·(unknown), Jing Li, Enxin Wang, Dongdong Xia, (unknown), Qiuhe Wang, Jie Yuan, Xiaomei Li, Jing Niu, Zhanxin Yin, Jielai Xia, Daiming Fan, Guohong Han	7
11	Myocardium injury biomarkers predict prognosis of critically ill coronavirus disease 2019 (COVID-19) patients 2020 ·Annals of Palliative Medicine ·(unknown), Sha Zhang, Xi Luo, Enxin Wang, Yang Bai, Zhe Li, Feng Li, Jing Ma, Haitao Liu	6
12	Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma 2020 ·Annals of Translational Medicine ·Zhexuan Wang, (unknown), Mengmeng Wang, Enxin Wang, Huichen Li, Lei Liu	15
13	Implications of Laboratory Tests in Disease Grading and Death Risk-Stratification of COVID-19: A Retrospective Study in Wuhan, China 2020 ·SSRN Electronic Journal ·(unknown), Enxin Wang, Shoujie Zhao, Jing Li, (unknown), Yongchao Zhang, Liang Cao, Haitao Liu, Yushu Dong, Fang Wang, Guobiao Liang, (unknown)	3
14	Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma 2019 ·BMC Cancer ·Enxin Wang, Dongdong Xia, Wei Bai, Jie Yuan, Xiaomei Li, Jing Niu, Zhanxin Yin, Jielai Xia, Hong Cai, Daiming Fan, Guohong Han, Lei Liu	10
15	As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib 2019 ·Canadian Journal of Gastroenterology and Hepatology ·Lei Liu, Enxin Wang, Lin Li, Dongyu Chen, Kun Peng, Mengmeng Wang, Guohong Han	3
16	Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis 2018 ·BMC Gastroenterology ·Lin Li, (unknown), Mengmeng Wang, Jie Hu, Enxin Wang, Yan Zhao, Lei Liu	41
17	Chemoembolization for Hepatocellular Carcinoma in Patients with Extrahepatic Spread: Prognostic Determinants and Appropriate Candidates 2017 ·Journal of Vascular and Interventional Radiology ·Enxin Wang, Lei Liu, Dongdong Xia, Wenjun Wang, Wei Bai, Qiuhe Wang, Jie Yuan, Xiaomei Li, Lei Zhang, Jing Niu, Zhanxin Yin, Jielai Xia, Hong Cai, Daiming Fan, Guohong Han	1
18	mRECIST response combined with sorafenib‐related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib 2016 ·International Journal of Cancer ·Wenjun Wang, Wei Bai, Enxin Wang, Yan Zhao, Lei Liu, Man Yang, Hong Cai, Dongdong Xia, Lei Zhang, Jing Niu, Zhanxin Yin, Zhuoli Zhang, Daiming Fan, Jielai Xia, Guohong Han	11
19	Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes. 1994 ·Drug Metabolism and Disposition ·Yuling Li, Enxin Wang, Christopher Patten, Laishun Chen, Caihua Yang	65
20	Structure of G.cntdot.T.cntdot.A triplet in an intramolecular DNA triplex 1992 ·Biochemistry ·Enxin Wang, Shiva Malek, Juli Feigon	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact